Deferoxamine Mesylate
The mesylate salt form of deferoxamine used parenterally to treat iron toxicity and chronic transfusional iron overload. The mesylate salt form is the standard pharmaceutical preparation for subcutaneous, intramuscular, or intravenous administration.
Moleküler Ağırlık
656,8000 g/mol
TPSA
269,00 Ų
Terapötik Alanlar
Etki Mekanizması
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
2D Yapı
Cite this structure
Embed this structure
SMILES
CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O
InChI
InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)
Molecular Formula
C26H52N6O11S
HBD / HBA
7 / 12
Döndürülebilir Bağlar
23
Ağır Atomlar
44
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
The mesylate salt form of deferoxamine used parenterally to treat iron toxicity and chronic transfusional iron overload. The mesylate salt form is the standard pharmaceutical preparation for subcutaneous, intramuscular, or intravenous administration.
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Yes, Deferoxamine Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1234. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 62881. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="deferoxamine-mesylate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/deferoxamine-mesylate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/deferoxamine-mesylate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/deferoxamine-mesylate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="deferoxamine-mesylate"></drugfyi-drug>